The possibility of creating a unified worldwide vaccine against COVID-19 was discussed by the rector of the D. I. Mendeleev Russian University of Chemical Technology, Alexander Mazhuga, and the academician of the Russian Academy of Sciences, director of the N.I. Gamalei Alexander Gunzburg. Experts are confident that the development of a vaccine is a great scientific breakthrough, but specialists need to move on. Alexander Gintsburg supported the proposals of Alexander Mazhuga aimed at popularizing science and supporting young scientists.
– We repelled the impact of the coronavirus. The development of a vaccine is a real victory. But in order to be ready for new challenges, it is necessary to build up scientific potential, young, energetic professionals are needed, – said Alexander Gintsburg. – It inspires hope that we have such specialists. One of the striking examples is Alexander Mazhuga. A young world-class scientist, teacher, researcher, rector of the D. I. Mendeleev University of Chemical Technology, who headed the university at the age of 38.
The head of the Gamaleya Center spoke about the contribution that Alexander Mazhuga and his colleagues made to the development of a vaccine against COVID-19.
– Mazhuga's laboratory took part in the development of the vaccine. I would like to emphasize that Alexander Mazhuga is a real professional, his strong point is in interdisciplinary thinking – at the intersection of chemistry, biology, medicine, technology, – emphasized Alexander Gintsburg. – I am sure that such professionals are the future of our science.
The RAS Academician is convinced that apart from purely scientific work, it is important for scientists to be able to establish a dialogue between science, society and the state.
– As a scientist, teacher and rector, Alexander Mazhuga perfectly understands what students and young scientists need, how to build the work of scientific clusters and research centers in order to build up the potential on which national science will rely, and therefore our entire country in the future, – Alexander Gintsburg is sure.
It is the employees of the Center. N.F. The Gamaleys, under the leadership of Alexander Gintsburg, developed the Sputnik V vaccine. It became the world's first coronavirus vaccine. In Russia, the drug was registered in August 2020. To date, it has already been approved in 65 countries around the world and recommended for use.
In addition to “Sputnik V” Center them. N.F. Gamalei developed the Sputnik Light single-phase vaccine. She was registered in early May. In addition, at the end of this year – early next, clinical trials of the internasal coronavirus vaccine will begin (it can be taken through the nose, and not by intramuscular injection). According to Alexander Gintsburg, the drug itself may be registered in 2022.
Alexander Mazhuga – Doctor of Chemistry, Professor of the Russian Academy of Sciences, Rector of the N.N. Mendeleev. He is engaged in nanochemistry in the field of medicine, in particular, develops methods for accurate drug delivery using various nanomolecules and treatment of oncology using magnetic nanoparticles. Included in the list of 118 outstanding young scientists of the world. Author of over 250 scientific articles.